(A) Outline of the experimental setup to assess the immunomodulatory effects of HIV-1 NEF on the generation of humoral immune responses. Antigen-specific interactions are established using HEL-OVA as model antigen with HEL-specific SWHEL B cells (BHEL) and OVA-specific OT-II CD4 T cells (CD4OT-II). 